NuScale Power Corporation (SMR) designs small modular reactor technology — factory-built, light-water nuclear plants marketed under its VOYGR brand — and holds the only U.S. Nuclear Regulatory Commission-certified small modular reactor design. It has no meaningful revenue until it books its first module order.
The stock was quoted at $3.685 in the opening hour of trading, down 3.15% from Thursday's close of $3.81. The decline puts shares below the prior session's $3.71 low and marks a new 52-week floor, extending a slide that has erased more than 70% of the company's value this year and roughly 84% from the $23.35 peak reached a year ago.
No verified news or fundamental catalyst found for the session. There was no NuScale press release, no SEC filing, and no new broker action timed to the move. What the tape shows is consistent with a continuation of selling pressure already in place, rather than a reaction to fresh information: the stock has closed lower in six of the last seven sessions, and rallies have been sold into at the open almost every day this week.
The pattern fits a market that has already repriced the story and is now repricing it further on momentum. Liquidity is not thin — turnover runs near 10% of the float daily — so a single large order is an unlikely explanation. More plausible is steady distribution from holders who bought the 2024–2025 nuclear hype cycle and are exiting ahead of another winter without a signed commercial contract.
The verified drivers behind the broader decline are well documented. Third-quarter results, reported November 5, showed revenue of $281,000 against $8.2 million a year earlier, as engineering work on the Romanian RoPower project wound down with nothing replacing it. The net loss was $43.65 million.
Analysts responded with a sweeping round of target cuts: Citigroup maintained a Sell rating and trimmed its target to $3.50, Cantor Fitzgerald reduced its target to $15, and Canaccord Genuity cut to $11 from $15. The consensus target has fallen to roughly $6.50–$8.60 from above $40 a year ago — still above spot, but falling fast.
Layered on top is litigation. A securities-fraud class action covering purchases between February 27 and September 10, 2026 alleges the company overstated its commercial prospects and cash runway; investor notices continue to circulate ahead of the January 11, 2027 deadline to seek lead-plaintiff status.
Most importantly, NuScale still has no binding order. Its commercialization partner ENTRA1 signed a non-binding agreement with the Tennessee Valley Authority for up to 6 gigawatts, but a definitive power purchase agreement has not been executed and management has offered no new timeline. Sector sentiment also took a hit in mid-November when Ontario Power Generation said Canada's first small modular reactor would miss its 2030 target and its budget.
Volume has been running above the roughly 34 million-share average, with 40.6 million shares changing hands in the prior session — evidence of active exit rather than apathy. Technically, the picture is decisively bearish: the stock trades far below its 20-day moving average near $5.09 and its 60-day average near $7.15, and every recent attempt to hold above $4 has failed.
The move is company-specific in its severity. NuScale's decline has outpaced diversified nuclear and utility peers, reflecting its binary dependence on a single unsigned contract rather than a broad market selloff.
The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. NuScale's score is 11 out of 100.
There was no verified news on the session, so catalyst strength was minimal; the pressure comes from an established narrative of collapsing revenue, downgrades, and an unsigned anchor contract. The price move was also unremarkable by the stock's own standards: today's 3.15% decline is roughly three-quarters of its 4.4% average absolute daily move, and 38 of the last 69 sessions produced moves of equal or greater size. Weak news plus a routine-sized move combine into a low score.
The decisive event remains a binding ENTRA1–TVA power purchase agreement naming a first plant and module count; without it, 2027 revenue estimates near $97 million have no foundation. Fourth-quarter results are expected in late February, and management has said operating expenses will stay roughly flat until projects begin. Investors should also watch progress on RoPower's engineering, procurement, and construction contract, further analyst revisions after the recent cuts, and any update on the class action's lead-plaintiff appointment in January. The key risk cuts both ways: roughly $1.9 billion in cash and investments exceeds the current market value, but a signed TVA deal triggers milestone payments to ENTRA1 that could consume a large share of that cushion, while continued share issuance dilutes per-share value.
Tickeron's Trending AI Robots page curates the platforms' strongest performers under current market conditions, drawn from a library of hundreds of AI trading bots covering thousands of tickers. Because bots differ widely in strategy, timeframe, performance metrics, and the symbols they trade, this section isolates those currently posting the best results rather than showing the full catalogue. For traders navigating a volatile name like NuScale, it offers a useful starting point — explore the page to compare live strategies and find the setups that fit your approach.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SMR declined for three days, in 273 of 314 cases, the price declined further within the following month. The odds of a continued downward trend are 87%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SMR as a result. In 73 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for SMR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 36 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
The Aroon Indicator for SMR entered a downward trend on November 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +24.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where SMR advanced for three days, in 196 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
SMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.011) is normal, around the industry mean (3.843). P/E Ratio (-2.309) is within average values for comparable stocks, (36.971). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (208.333) is also within normal values, averaging (189.487).
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. SMR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialMachinery